The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine

This study suggests that ketamine antinociception depends at least in part on AEA release and CB1 cannabinoid receptor activation in inflammatory conditions. This study could potentially help clinicians in the use of ketamine as a peripheral analgesic for inflammatory pain.